BACKGROUND: Primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI) improves outcome in comparison to fibrinolysis. However, it is unclear whether patients treated in interventional facilities with 24-h primary PCI service have lower rates of adverse events. METHODS: We analyzed data of consecutive patients with STEMI prospectively enrolled in the German Acute Coronary Syndromes registry between July 2000 and November 2002 who were admitted to hospitals with catheterisation laboratory. RESULTS: Overall 6,350 patients were divided into two groups: 2,779 (43.8%) were treated in hospitals with and 3,571 (56.2%) without 24-h on-call cardiac catheter laboratories. 83.0% of the patients at facilities with and only 69.9% of the patients at facilities without 24-h PCI service received early reperfusion therapy (P < 0.001). Hospital death (7.4% vs. 9.9%, P < 0.001), non-fatal myocardial reinfarction (2.5% vs. 6.4%, P < 0.0001) and stroke (0.3 vs. 1.0%, P < 0.01) occurred significantly less often in patients treated in hospitals with 24-h primary PCI service. After adjustment for the confounding factors in the propensity score analysis the 24-h on-call strategy remained superior for the combined endpoint of death, reinfarction and stroke (OR 0.63, 95% CI 0.54-0.75). CONCLUSIONS: In clinical practice the rate of patients receiving reperfusion therapy was significantly higher in hospitals with 24-h primary PCI service which was associated with an improved in-hospital outcome. Though the data was collected at a time that does not completely represent current clinical practice, these results could have an impact on planning efficient infarct networks in the future.
BACKGROUND: Primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI) improves outcome in comparison to fibrinolysis. However, it is unclear whether patients treated in interventional facilities with 24-h primary PCI service have lower rates of adverse events. METHODS: We analyzed data of consecutive patients with STEMI prospectively enrolled in the German Acute Coronary Syndromes registry between July 2000 and November 2002 who were admitted to hospitals with catheterisation laboratory. RESULTS: Overall 6,350 patients were divided into two groups: 2,779 (43.8%) were treated in hospitals with and 3,571 (56.2%) without 24-h on-call cardiac catheter laboratories. 83.0% of the patients at facilities with and only 69.9% of the patients at facilities without 24-h PCI service received early reperfusion therapy (P < 0.001). Hospital death (7.4% vs. 9.9%, P < 0.001), non-fatal myocardial reinfarction (2.5% vs. 6.4%, P < 0.0001) and stroke (0.3 vs. 1.0%, P < 0.01) occurred significantly less often in patients treated in hospitals with 24-h primary PCI service. After adjustment for the confounding factors in the propensity score analysis the 24-h on-call strategy remained superior for the combined endpoint of death, reinfarction and stroke (OR 0.63, 95% CI 0.54-0.75). CONCLUSIONS: In clinical practice the rate of patients receiving reperfusion therapy was significantly higher in hospitals with 24-h primary PCI service which was associated with an improved in-hospital outcome. Though the data was collected at a time that does not completely represent current clinical practice, these results could have an impact on planning efficient infarct networks in the future.
Authors: Mauro Moscucci; David Share; Dean Smith; Michael J O'Donnell; Arthur Riba; Richard McNamara; Thomas Lalonde; Anthony C Defranco; Kirit Patel; Eva Kline Rogers; Chris D'Haem; Milind Karve; Kim A Eagle Journal: J Am Coll Cardiol Date: 2005-08-16 Impact factor: 24.094
Authors: J M Juliard; D Himbert; J L Golmard; P Aubry; G J Karrillon; A Boccara; H Benamer; P G Steg Journal: J Am Coll Cardiol Date: 1997-07 Impact factor: 24.094
Authors: J G Canto; N R Every; D J Magid; W J Rogers; J A Malmgren; P D Frederick; W J French; A J Tiefenbrunn; V K Misra; C I Kiefe; H V Barron Journal: N Engl J Med Date: 2000-05-25 Impact factor: 91.245
Authors: W D Weaver; R J Simes; A Betriu; C L Grines; F Zijlstra; E Garcia; L Grinfeld; R J Gibbons; E E Ribeiro; M A DeWood; F Ribichini Journal: JAMA Date: 1997-12-17 Impact factor: 56.272
Authors: R Zahn; S Schuster; R Schiele; K Seidl; T Voigtländer; J Meyer; K E Hauptmann; M Gottwik; G Berg; T Kunz; U Gieseler; M Jakob; J Senges Journal: Catheter Cardiovasc Interv Date: 1999-02 Impact factor: 2.692
Authors: J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel Journal: N Engl J Med Date: 1999-08-26 Impact factor: 91.245
Authors: Elliott M. Antman; Daniel T. Anbe; Paul Wayne Armstrong; Eric R. Bates; Lee A. Green; Mary Hand; Judith S. Hochman; Harlan M. Krumholz; Frederick G. Kushner; Gervasio A. Lamas; Charles J. Mullany; Joseph P. Ornato; David L. Pearle; Michael A. Sloan; Sidney C. Smith; Joseph S. Alpert; Jeffrey L. Anderson; David P. Faxon; Valentin Fuster; Raymond J. Gibbons; Gabriel Gregoratos; Jonathan L. Halperin; Loren F. Hiratzka; Sharon Ann Hunt; Alice K. Jacobs; Joseph P. Ornato Journal: J Am Coll Cardiol Date: 2004-08-04 Impact factor: 24.094
Authors: Ulrike M Müller; Ingo Eitel; Kristina Eckrich; Sandra Erbs; Axel Linke; Sven Möbius-Winkler; Meinhard Mende; Gerhard C Schuler; Holger Thiele Journal: Clin Res Cardiol Date: 2010-10-24 Impact factor: 5.460
Authors: Alban Dibra; Klaus Tiroch; Stefanie Schulz; Henning Kelbaek; Christian Spaulding; Gerrit J Laarman; Marco Valgimigli; Emilio Di Lorenzo; Christoph Kaiser; Ilkka Tierala; Julinda Mehilli; Gianluca Campo; Leif Thuesen; Maarten A Vink; Martin J Schalij; Roberto Violini; Albert Schömig; Adnan Kastrati Journal: Clin Res Cardiol Date: 2010-03-11 Impact factor: 5.460
Authors: Christoph Liebetrau; Sebastian Szardien; Johannes Rixe; Mariella Woelken; Andreas Rolf; Timm Bauer; Holger Nef; Helge Möllmann; Christian Hamm; Michael Weber Journal: Clin Res Cardiol Date: 2010-09-21 Impact factor: 5.460
Authors: Ralf Birkemeyer; Andreas Rillig; Annette Koch; Tomislav Miljak; Markus Kunze; Udo Meyerfeldt; Wolfgang Steffen; Martin Soballa; Carsten Ranke; Roland Prassler; Albert Benzing; Werner Jung Journal: Clin Res Cardiol Date: 2010-07-06 Impact factor: 5.460
Authors: Gjin Ndrepepa; Dritan Keta; Stefanie Schulz; Robert A Byrne; Julinda Mehilli; Jürgen Pache; Melchior Seyfarth; Albert Schömig; Adnan Kastrati Journal: Clin Res Cardiol Date: 2009-09-10 Impact factor: 5.460
Authors: Ingo Wickenbrock; Christian Perings; Petra Maagh; Ivo Quack; Marc van Bracht; Magnus W Prull; Gunnar Plehn; Hans-Joachim Trappe; Axel Meissner Journal: Clin Res Cardiol Date: 2009-10-23 Impact factor: 5.460